Literature DB >> 16205573

Evaluation of genotype-phenotype associations in leber congenital amaurosis.

Jennifer A Galvin1, Gerald A Fishman, Edwin M Stone, Robert K Koenekoop.   

Abstract

PURPOSE: To describe the clinical phenotypes associated with various genotypes known to cause Leber congenital amaurosis (LCA).
METHODS: One hundred ten LCA patients were screened for various probable disease-causing gene sequence variations. Those patients with a probable disease-causing sequence variation in one of six genotypes were recalled for a follow-up examination. Evaluations included assessment of visual acuity, slit-lamp biomicroscopy, and dilated fundus examination. When possible, Goldmann perimetry was also performed.
RESULTS: Of the 37 LCA patients with suspected disease-causing sequence variations, 7 had an AIPL1 variation, 8, a CRB1 variation, 2, a CRX variation, 4, a GUCY2D variation, 11, an RPE65 variation, and 5, an RPGRIP1 variation. Across the 6 genotypes, we observed a wide range of visual acuities from 20/40 to no light perception. The widest range of vision was noted for patients with a CRB1 or RPE65 variation. Younger patients with an AIPL1 or RPGRIP1 variation were found to have severely reduced vision. Drusenlike deposits were more selectively observed in patients with mutations in the AIPL1, CRB1, RPE65, and RPGRIP1 genes, whereas focal regions of peripheral chorioretinal atrophy were observed only in patients with AIPL1 or RPE65 variations. Neurologic, intellectual, or psychomotor developmental delay was noted in 8.1% of our cohort.
CONCLUSIONS: There was considerable overlap of phenotypic expression in six genetic subtypes in our LCA cohort. However, phenotypic trends were noted in our patients' visual acuities and posterior segment findings within genotypes. These findings have practical value for genetic screening strategies for LCA patients based upon phenotype as well as for counseling patients on their visual prognosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16205573     DOI: 10.1097/00006982-200510000-00016

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  32 in total

Review 1.  CRB1 mutations in inherited retinal dystrophies.

Authors:  Kinga Bujakowska; Isabelle Audo; Saddek Mohand-Saïd; Marie-Elise Lancelot; Aline Antonio; Aurore Germain; Thierry Léveillard; Mélanie Letexier; Jean-Paul Saraiva; Christine Lonjou; Wassila Carpentier; José-Alain Sahel; Shomi S Bhattacharya; Christina Zeitz
Journal:  Hum Mutat       Date:  2011-12-27       Impact factor: 4.878

2.  Gene therapy using self-complementary Y733F capsid mutant AAV2/8 restores vision in a model of early onset Leber congenital amaurosis.

Authors:  Cristy A Ku; Vince A Chiodo; Sanford L Boye; Andrew F X Goldberg; Tiansen Li; William W Hauswirth; Visvanathan Ramamurthy
Journal:  Hum Mol Genet       Date:  2011-08-31       Impact factor: 6.150

Review 3.  Leber congenital amaurosis, from darkness to light: An ode to Irene Maumenee.

Authors:  Razek Georges Coussa; Irma Lopez Solache; Robert K Koenekoop
Journal:  Ophthalmic Genet       Date:  2017-01-17       Impact factor: 1.803

4.  Residual electroretinograms in young Leber congenital amaurosis patients with mutations of AIPL1.

Authors:  Mark E Pennesi; Niamh B Stover; Edwin M Stone; Pei-Wen Chiang; Richard G Weleber
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-17       Impact factor: 4.799

5.  Retinal degeneration in children: dark adapted visual threshold and arteriolar diameter.

Authors:  Ronald M Hansen; Susan E Eklund; Ilan Y Benador; Julie A Mocko; James D Akula; Yao Liu; M Elena Martinez-Perez; Anne B Fulton
Journal:  Vision Res       Date:  2007-08-31       Impact factor: 1.886

6.  Differential macular morphology in patients with RPE65-, CEP290-, GUCY2D-, and AIPL1-related Leber congenital amaurosis.

Authors:  Sirichai Pasadhika; Gerald A Fishman; Edwin M Stone; Martin Lindeman; Ruth Zelkha; Irma Lopez; Robert K Koenekoop; Mahnaz Shahidi
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-03       Impact factor: 4.799

7.  Aryl Hydrocarbon Receptor-interacting Protein-like 1 Is an Obligate Chaperone of Phosphodiesterase 6 and Is Assisted by the γ-Subunit of Its Client.

Authors:  Kota N Gopalakrishna; Kimberly Boyd; Ravi P Yadav; Nikolai O Artemyev
Journal:  J Biol Chem       Date:  2016-06-07       Impact factor: 5.157

8.  Interaction of aryl hydrocarbon receptor-interacting protein-like 1 with the farnesyl moiety.

Authors:  Anurima Majumder; Kota N Gopalakrishna; Pallavi Cheguru; Lokesh Gakhar; Nikolai O Artemyev
Journal:  J Biol Chem       Date:  2013-06-04       Impact factor: 5.157

Review 9.  Aberrant protein trafficking in retinal degenerations: The initial phase of retinal remodeling.

Authors:  Katie L Bales; Alecia K Gross
Journal:  Exp Eye Res       Date:  2015-11-26       Impact factor: 3.467

10.  The RPGRIP1-deficient dog, a promising canine model for gene therapy.

Authors:  Elsa Lhériteau; Lyse Libeau; Knut Stieger; Jack-Yves Deschamps; Alexandra Mendes-Madeira; Nathalie Provost; Francoise Lemoine; Cathryn Mellersh; N Matthew Ellinwood; Yan Cherel; Philippe Moullier; Fabienne Rolling
Journal:  Mol Vis       Date:  2009-02-18       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.